Clinical trial · Observational
Endoscopic Ultrasound Radiofrequency Ablation, Database Repository
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of having this database is to collect data related to endoscopic ultrasound RFA procedures performed by Indiana University EUS physicians for the treatment of tumors or adenopathy. This database is a repository database only, all information will be obtained in the electronic medical record. No additional clinical procedures will be performed outside current standard of care for endoscopic ultrasound. The patient will have already signed an informed consent for the endoscopic ultrasound. Subjects will be entered into the database for up to 10 years after the most recent procedure.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreatic Neoplasm | Pancreatic Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (3)
- measure
- Incidence of any procedural complications that occur during the procedure on date of procedure.
- timeFrame
- Day of procedure
- description
- This data will be used for to determine the clinical impact and safety of these procedures.
- measure
- Rate of patient report of symptoms related to procedure (Acute pancreatitis, abdominal pain, infection/abscess, venous thrombosis, & fever)
- timeFrame
- 1 week following procedure
- description
- 1 week phone follow up
- measure
- Rate of patient report of symptoms related to procedure (Acute pancreatitis, abdominal pain, infection/abscess, venous thrombosis, & fever)
- timeFrame
- 2 weeks following procedure
- description
- 2 week phone follow up
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 14 Years
Show eligibility criteria text
Inclusion Criteria: Subjects 14 years of age and older Referral for the treatment of a benign or malignant tumor or adenopathy Exclusion Criteria: * Subjects less than 14 years of age Unable to comprehend the study consent due to language or disability
References
Publications (0)
Data not yet available